1. Japan Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Stella Chemifa Corporation

Stella Chemifa Corporation

26.20
EUR
-0.80
(-2.96%)
319.80MMarket Cap
Nov 12Next Earn
Stella Chemifa Corporation
FRA:SLO
(Frankfurt Stock Exchange)

Recent

price

26.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
JPY
2,302.63
2,379.95
2,318.44
2,370.78
2,361.95
2,292.61
2,479.03
2,650.95
2,972.51
2,612.02
2,564.36
2,940.63
2,885.86
2,532.1
3,024
3,110.11
- -
Revenue per Share
147.33
76.67
160.04
63.76
110.18
110.26
234.53
100.45
181.99
149
230.69
422.93
185.96
153.44
241
258.45
- -
Basic EPS, GAAP
107.08
-308.89
115.02
164.1
-34.92
338.28
315.42
-189.39
303.57
30.05
383.72
211.54
85.31
56.8
245.42
120.1
- -
Free Cash Flow per Basic Share
38.86
37.89
38.59
38.42
38.34
38.34
40.2
43.92
41.2
47.24
45.61
49.91
67.29
90.82
181.42
171.57
- -
Dividend per Share
1,488.66
1,519.43
1,667.83
1,739.5
1,839.32
2,076.01
2,281.97
2,418.56
2,542.17
2,637.92
2,830.53
3,373.72
3,572.54
3,679.76
3,791.62
3,917.97
- -
Book Value per Share
1,438.74
1,513.66
1,661.5
1,726.5
1,827.99
2,063.84
2,271.49
2,407.41
2,498.42
2,587.2
2,790.26
3,343.75
3,550.81
3,667.37
3,788.06
3,912.31
- -
Tangible Book Value per Share
12
12
12
12
12
12
12
13
13
13
13
13
12
12
12
12
12
Basic Weighted Avg Shares
28,320
29,271
28,118
28,447
28,341
27,509
29,850
33,622
38,384
33,729
32,893
37,296
35,382
30,446
36,288
36,799
- -
Sales/Revenue/Turnover
12.3
8.22
9.56
3.82
0.33
5.05
14.65
7.05
9.18
7.14
12.41
12.29
9.93
8.94
11.96
12.62
- -
Operating Margin (%)
2,755
2,591
2,821
3,352
3,626
3,525
3,117
3,344
3,253
3,236
3,039
2,713
2,593
2,768
2,812
2,889
- -
Depreciation Expense
1,812
943
1,941
765
1,322
1,323
2,824
1,274
2,350
1,924
2,959
5,364
2,280
1,845
2,892
3,058
- -
Net Income, GAAP
40.59
52.49
37.17
47.41
32.69
15.93
31.06
40.1
39.77
32.41
31.82
26.52
41.09
29.74
32.01
30.67
- -
Effective Tax Rate (%)
6.4
3.22
6.9
2.69
4.66
4.81
9.46
3.79
6.12
5.7
9
14.38
6.44
6.06
7.97
8.31
- -
Profit Margin (%)
4,086
-129
3,775
3,223
4,685
11,088
15,503
15,484
18,215
18,834
20,040
20,777
19,721
20,112
20,055
19,844
- -
Working Capital
7,396
5,984
8,213
7,863
8,256
6,939
7,962
6,203
6,857
6,755
4,751
2,003
1,070
1,949
2,424
2,871
- -
LT Debt
18,615
18,977
20,300
21,197
22,405
26,567
29,516
32,483
33,915
34,726
36,755
42,726
43,160
44,500
44,991
48,059
- -
Total Equity
6.17
3.29
4.7
1.51
0.16
2.96
6.99
3.17
4.62
3.48
6.03
7.02
4.27
3.94
5.84
6.09
- -
Return on Invested Capital (%)
5.72
2.99
5.77
2.26
3.68
3.61
7.16
3.38
5.57
5.13
7.1
12.24
5.45
3.89
5.89
6
- -
Return on Capital (%)
10.2
5.1
10.03
3.74
6.16
5.63
10.66
4.3
7.34
5.75
8.41
13.67
5.36
4.23
6.5
6.61
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
2,839
2,684
- -
LT Borrowings
3,384
2,871
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
47,980
58,660
80,253

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
30,300
28,929
- -
Cash, Cash Equivalents & STI
16,755
14,817
- -
Accounts Receivable, Net
7,788
7,333
- -
Inventories
5,371
6,372
- -
Total Current Liabilities
8,688
9,085
- -
Payables & Accruals
- -
- -
- -
ST Debt
2,839
2,684
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.21%
5.66%
6.82%
Free Cash Flow
78.38%
27.65%
-51.75%
Net Income, GAAP
24.59%
13.44%
5.74%
Sales/Revenue/Turnover
3.56%
2.98%
1.41%
Total Cash Common Dividend
18.99%
32.7%
-6.75%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
36,288
2026
- -
- -
- -
- -
36,799
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
241
2026
- -
- -
- -
- -
258.45
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
181.42
2026
- -
- -
- -
- -
171.57
2027
- -
- -
- -
- -
- -
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Stella Chemifa Corporation manufactures and sells high-purity chemicals, primarily fluorides, for semiconductors, batteries, optical materials, and other industrial applications; its core products include ultra-high purity hydrofluoric acid and buffered hydrogen fluoride for wet etching and cleaning of silicon wafers, lithium hexafluorophosphate as an electrolyte for lithium-ion secondary batteries, enriched boron for nuclear energy neutron shielding, boron trifluoride gas as a reactive catalyst, fluorides for optical lenses and surface treatments, and GMP-compliant additives for toothpaste. The company operates through segments encompassing high-purity chemicals, transportation and logistics via subsidiary Blue Express Inc., medical research, cosmetics, energy management, and other services such as insurance agency and automobile maintenance. Founded in 1916 and headquartered in Osaka, Japan, Stella Chemifa conducts operations in Japan with factories in Sakai, Izumiotsu, and Kitakyushu, alongside international subsidiaries and affiliates in Singapore, China, and South Korea. Recent developments include the completion of the Next Generation Materials Research Lab in its Sanpo Factory in 2023 to advance new product development; in 2022, Stella Pharma Corporation transitioned from a consolidated subsidiary to an equity-method affiliate following its listing on the Tokyo Stock Exchange Growth Market in 2021; and the company maintains its listing on the Tokyo Stock Exchange Prime Market with ongoing expansions in production capacity exceeding 100,000 tons annually for high-purity chemicals to meet global semiconductor demand.